Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2.16Prev. Close
2.25Volume
72,532Total traded value
0.02 CrUpper Circuit
2.36Lower Circuit
2.14Fundamentals
| Market Cap | ₹9.00Cr |
| ROE | -6.62% |
| P/E Ratio(TTM) | -28.13 |
| EPS(TTM) | -0.08 |
| P/B Ratio | 1.95 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.27 |
| Book Value | 1.15 |
| Debt to Equity | 2.20 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Vivanza Biosciences
Vivanza Biosciences is a leading Indian pharmaceutical company dedicated to providing high-quality medicines and healthcare solutions through research, development, and manufacturing. The company's primary mission is to contribute to a healthier society by improving the lives of people on a global scale. It demonstrated steady performance by earning a standalone revenue of ₹14.46 crores during the financial year 2023-24.;
| Parent Organisation | Vivanza Biosciences Limited |
| Managing Director | Mr. Jayendra Mehta |
| BSE Symbol | 530057 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.69 | ||
| Cohance Lifesciences | NA (0.00%) | 71.09 | ||
| Wockhardt | NA (0.00%) | -423.74 |